Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex
Lysergic acid diethylamide (LSD) and psilocybin are serotonergic psychedelic compounds with potential in the treatment of mental health disorders. Past neuroimaging investigations have revealed that both compounds can elicit significant changes to whole-brain functional organization and dynamics. A...
Main Authors: | Manesh Girn, Leor Roseman, Boris Bernhardt, Jonathan Smallwood, Robin Carhart-Harris, R. Nathan Spreng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | NeuroImage |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1053811922003445 |
Similar Items
-
Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains
by: Thomas F. Varley, et al.
Published: (2020-10-01) -
Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique
by: Sharday Mosurinjohn, et al.
Published: (2023-04-01) -
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
by: Leor Roseman, et al.
Published: (2018-01-01) -
Human electromagnetic and haemodynamic networks systematically converge in unimodal cortex and diverge in transmodal cortex.
by: Golia Shafiei, et al.
Published: (2022-08-01) -
Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain’s control energy landscape
by: S. Parker Singleton, et al.
Published: (2022-10-01)